American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
The incidence of adverse drug events (ADEs), preventable ADEs, and potential ADEs was determined using pharmacist surveillance. Drug classes associated with ADEs were also identified. ⋯ Pharmacist surveillance revealed that 4.4 ADEs occurred per 100 patient-days, over half of which were preventable. All preventable and potential ADEs occurred during the ordering and administration stages of medication delivery.
-
Am J Health Syst Pharm · Jul 2004
ReviewOmalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.
The pharmacology, efficacy, dosage, adverse events, and economics of omalizumab are discussed. ⋯ Omalizumab should be considered as a second-line therapy for patients with moderate to severe persistent allergic asthma.
-
Medication errors reported to FDA as adverse events in which methotrexate was identified as a possible contributor were studied. ⋯ A review of medication errors involving methotrexate revealed that errors occurred during all phases of use, often resulted from confusion about dosage, and often caused death or other serious adverse effects.